CA Patent

CA3112278A1 — Artificial tear, contact lens and drug vehicle compositions and methods of use thereof

Assigned to Ps Therapy Ltd · Expires 2020-03-26 · 6y expired

What this patent protects

The invention provides artificial tear compositions, artificial tear-gel compositions, contact lens storage compositions, contact lens treatment compositions, ophthalmological drug vehicle compositions and topical drug vehicle compositions comprising one or more nonionic surfacta…

USPTO Abstract

The invention provides artificial tear compositions, artificial tear-gel compositions, contact lens storage compositions, contact lens treatment compositions, ophthalmological drug vehicle compositions and topical drug vehicle compositions comprising one or more nonionic surfactants with one or more non-Newtonian viscosity enhancing excipients and one or more of a polyol and or an electrolyte and methods of their use.

Drugs covered by this patent

Patent Metadata

Patent number
CA3112278A1
Jurisdiction
CA
Classification
—
Expires
2020-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Ps Therapy Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.